Clinton Group’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-43,690
Closed -$820K 480
2017
Q4
$820K Buy
+43,690
New +$869K 0.07% 269
2017
Q2
Sell
-38,584
Closed -$1.08M 830
2017
Q1
$1.08M Sell
38,584
-4,705
-11% -$123K 0.06% 412
2016
Q4
$1.06M Buy
43,289
+14,041
+48% +$322K 0.06% 349
2016
Q3
$736K Buy
29,248
+14,679
+101% +$352K 0.03% 574
2016
Q2
$301K Buy
+14,569
New +$304K 0.01% 745
2013
Q4
Sell
-44,471
Closed -$1.02M 402
2013
Q3
$1.02M Buy
+44,471
New +$1.1M 0.31% 59

Other funds holding SBRA

Clinton Group's SBRA Position: Q1 2018 in Review

Clinton Group sold out of Sabra Healthcare REIT (SBRA) in Q1 2018, closing a stake of 43,690 shares — an estimated $820K sold.

Clinton Group first reported a position in SBRA in Q3 2013 and held it in 6 quarters. The position peaked at $1.08M in Q1 2017. 327 funds tracked by Wall St. Rank hold SBRA as of Q1 2018.

  • Clinton Group reported no remaining Sabra Healthcare REIT position as of Q1 2018 after selling out during the quarter.
  • Clinton Group sold 43,690 Sabra Healthcare REIT shares in Q1 2018, an estimated $820K.
  • Clinton Group first reported a position in Sabra Healthcare REIT in Q3 2013 and held it in 6 quarters.
  • Clinton Group's Sabra Healthcare REIT position peaked at $1.08M in Q1 2017.
  • 327 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2018.

Based on Clinton Group's 13F filing for Q1 2018, filed 14 May 2018.